Taiwan Bio Therapeutics (ROCO:6892) Change In Inventory: NT$-6.01 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6892 Taiwan Bio Therapeutics Inc ROCO:6892
30 GF Score
Price NT$25.05
GF Value NT$14.38
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Taiwan Bio Therapeutics Change In Inventory?

Taiwan Bio Therapeutics ROCO:6892 -0.20% 30 Change In Inventory is NT$-6.01 Mil as of Jun. 2026. GuruFocus rates ROCO:6892 with a GF Score™ of 30/100 and a GF Value™ of NT$14.38 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Taiwan Bio Therapeutics's change in inventory for the quarter that ended in Jun. 2026 was NT$0.00 Mil. It means Taiwan Bio Therapeutics's inventory stayed the same from Dec. 2025 to Jun. 2026 .

Taiwan Bio Therapeutics's change in inventory for the fiscal year that ended in Dec. 2025 was NT$0.27 Mil. It means Taiwan Bio Therapeutics's inventory declined by NT$0.27 Mil from Dec. 2024 to Dec. 2025 .

Taiwan Bio Therapeutics's Total Inventories for the quarter that ended in Jun. 2026 was NT$34.06 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Taiwan Bio Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Taiwan Bio Therapeutics  (ROCO:6892) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Taiwan Bio Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=32.571/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Taiwan Bio Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 32.571
=0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Taiwan Bio Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=32.571 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Bio Therapeutics Change In Inventory Related Terms

Taiwan Bio Therapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Taiwan Bio Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Bio Therapeutics Change In Inventory Chart

Taiwan Bio Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -5.54 -25.24 -9.88 9.61 0.27

Taiwan Bio Therapeutics Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 -3.36 -2.65 0.00 0.00
ROCO:6892
30GF Score
Taiwan Bio Therapeutics Inc ROCO:6892
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiwan Bio Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-6.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$-6.01 Mil mean?
Taiwan Bio Therapeutics (ROCO:6892) has a Change In Inventory of NT$-6.01 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Taiwan Bio Therapeutics and its competitors.
Is Taiwan Bio Therapeutics' Change In Inventory too high?
Taiwan Bio Therapeutics' current Change In Inventory is NT$-6.01 Mil. Overall, Taiwan Bio Therapeutics has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Taiwan Bio Therapeutics' Change In Inventory compare to VRTX and REGN?
Taiwan Bio Therapeutics' Change In Inventory of NT$-6.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Taiwan Bio Therapeutics and its competitors. Taiwan Bio Therapeutics's current Change In Inventory is NT$-6.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Bio Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Bio Therapeutics (ROCO:6892) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$14.38, compared to a current price of NT$25.05 — trading 74.2% above its estimated fair value. The current Change In Inventory is NT$-6.01 Mil. Taiwan Bio Therapeutics' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Taiwan Bio Therapeutics (ROCO:6892), the current Change In Inventory is NT$-6.01 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiwan Bio Therapeutics (ROCO:6892) Overvalued in 2026?

Based on GuruFocus' analysis, Taiwan Bio Therapeutics stock appears to be overvalued. The current stock price of NT$25.05 is trading 74.2% above its estimated GF Value™ of NT$14.38. GuruFocus considers Taiwan Bio Therapeutics to be Significantly Overvalued.

Key valuation signals for ROCO:6892:

  • Change In Inventory: NT$-6.01 Mil
  • GF Value™: NT$14.38 vs. price of NT$25.05 (74.2% above fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6892 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Taiwan Bio Therapeutics Business Description

Address Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744
Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.
30GF Score

Get the complete analysis for ROCO:6892

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.05
Price
NT$14.38
GF Value